The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Chagas Disease Treatment-Global Market Insights and Sales Trends 2025
Synopsis
This report focus on drugs for treating Chagas Disease. Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America, due to migration of people from Latin America to others countries.
The global Chagas Disease Treatment market size is expected to reach US$ 986 million by 2029, growing at a CAGR of 7.8% from 2023 to 2029. The market is mainly driven by the significant applications of Chagas Disease Treatment in various end use industries. The expanding demands from the Hospitals, Retail Pharmacies and Online Pharmacies,, are propelling Chagas Disease Treatment market. Benznidazole, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nifurtimox segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chagas Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Chagas Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chagas Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chagas Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chagas Disease Treatment covered in this report include Nortec Quimica SA, Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A, Laboratorio Farmaceutico De Pernambuco, AstraZeneca, Daiichi Sankyo Company Ltd, Eisai Co Ltd and GlaxoSmithKline Plc, etc.
The global Chagas Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Nortec Quimica SA
Bayer AG
Laboratorio Elea Phoenix SA
Maprimed S.A
Laboratorio Farmaceutico De Pernambuco
AstraZeneca
Daiichi Sankyo Company Ltd
Eisai Co Ltd
GlaxoSmithKline Plc
KaloBios Pharmaceuticals, Inc
Kancera AB
Novartis AG
Oblita Therapeutics BVBA
Sanofi Aventis
Grupo Praxis Pharmaceutical SA
Johnson & Johnson
ELEA SACIF Laboratory
F. Hoffmann-La Roche Ltd.
Global Chagas Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chagas Disease Treatment market, Segment by Type:
Benznidazole
Nifurtimox
Global Chagas Disease Treatment market, by Application
Hospitals
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Chagas Disease Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Chagas Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
This report focus on drugs for treating Chagas Disease. Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America, due to migration of people from Latin America to others countries.
The global Chagas Disease Treatment market size is expected to reach US$ 986 million by 2029, growing at a CAGR of 7.8% from 2023 to 2029. The market is mainly driven by the significant applications of Chagas Disease Treatment in various end use industries. The expanding demands from the Hospitals, Retail Pharmacies and Online Pharmacies,, are propelling Chagas Disease Treatment market. Benznidazole, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nifurtimox segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chagas Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Chagas Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chagas Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chagas Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chagas Disease Treatment covered in this report include Nortec Quimica SA, Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A, Laboratorio Farmaceutico De Pernambuco, AstraZeneca, Daiichi Sankyo Company Ltd, Eisai Co Ltd and GlaxoSmithKline Plc, etc.
The global Chagas Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Nortec Quimica SA
Bayer AG
Laboratorio Elea Phoenix SA
Maprimed S.A
Laboratorio Farmaceutico De Pernambuco
AstraZeneca
Daiichi Sankyo Company Ltd
Eisai Co Ltd
GlaxoSmithKline Plc
KaloBios Pharmaceuticals, Inc
Kancera AB
Novartis AG
Oblita Therapeutics BVBA
Sanofi Aventis
Grupo Praxis Pharmaceutical SA
Johnson & Johnson
ELEA SACIF Laboratory
F. Hoffmann-La Roche Ltd.
Global Chagas Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chagas Disease Treatment market, Segment by Type:
Benznidazole
Nifurtimox
Global Chagas Disease Treatment market, by Application
Hospitals
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Chagas Disease Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Chagas Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Chagas Disease Treatment Market Overview
1.1 Chagas Disease Treatment Product Overview
1.2 Chagas Disease Treatment Market Segment by Type
1.2.1 Benznidazole
1.2.2 Nifurtimox
1.3 Global Chagas Disease Treatment Market Size by Type
1.3.1 Global Chagas Disease Treatment Market Size Overview by Type (2018-2029)
1.3.2 Global Chagas Disease Treatment Historic Market Size Review by Type (2018-2023)
1.3.3 Global Chagas Disease Treatment Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Chagas Disease Treatment Sales Breakdown by Type (2018-2023)
1.4.2 Europe Chagas Disease Treatment Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Chagas Disease Treatment Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Chagas Disease Treatment Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Chagas Disease Treatment Sales Breakdown by Type (2018-2023)
2 Global Chagas Disease Treatment Market Competition by Company
2.1 Global Top Players by Chagas Disease Treatment Sales (2018-2023)
2.2 Global Top Players by Chagas Disease Treatment Revenue (2018-2023)
2.3 Global Top Players by Chagas Disease Treatment Price (2018-2023)
2.4 Global Top Manufacturers Chagas Disease Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Chagas Disease Treatment Market Competitive Situation and Trends
2.5.1 Chagas Disease Treatment Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Chagas Disease Treatment Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chagas Disease Treatment as of 2022)
2.7 Date of Key Manufacturers Enter into Chagas Disease Treatment Market
2.8 Key Manufacturers Chagas Disease Treatment Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Chagas Disease Treatment Status and Outlook by Region
3.1 Global Chagas Disease Treatment Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Chagas Disease Treatment Historic Market Size by Region
3.2.1 Global Chagas Disease Treatment Sales in Volume by Region (2018-2023)
3.2.2 Global Chagas Disease Treatment Sales in Value by Region (2018-2023)
3.2.3 Global Chagas Disease Treatment Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Chagas Disease Treatment Forecasted Market Size by Region
3.3.1 Global Chagas Disease Treatment Sales in Volume by Region (2024-2029)
3.3.2 Global Chagas Disease Treatment Sales in Value by Region (2024-2029)
3.3.3 Global Chagas Disease Treatment Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Chagas Disease Treatment by Application
4.1 Chagas Disease Treatment Market Segment by Application
4.1.1 Hospitals
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Chagas Disease Treatment Market Size by Application
4.2.1 Global Chagas Disease Treatment Market Size Overview by Application (2018-2029)
4.2.2 Global Chagas Disease Treatment Historic Market Size Review by Application (2018-2023)
4.2.3 Global Chagas Disease Treatment Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Chagas Disease Treatment Sales Breakdown by Application (2018-2023)
4.3.2 Europe Chagas Disease Treatment Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Chagas Disease Treatment Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Chagas Disease Treatment Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Chagas Disease Treatment Sales Breakdown by Application (2018-2023)
5 North America Chagas Disease Treatment by Country
5.1 North America Chagas Disease Treatment Historic Market Size by Country
5.1.1 North America Chagas Disease Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Chagas Disease Treatment Sales in Volume by Country (2018-2023)
5.1.3 North America Chagas Disease Treatment Sales in Value by Country (2018-2023)
5.2 North America Chagas Disease Treatment Forecasted Market Size by Country
5.2.1 North America Chagas Disease Treatment Sales in Volume by Country (2024-2029)
5.2.2 North America Chagas Disease Treatment Sales in Value by Country (2024-2029)
6 Europe Chagas Disease Treatment by Country
6.1 Europe Chagas Disease Treatment Historic Market Size by Country
6.1.1 Europe Chagas Disease Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Chagas Disease Treatment Sales in Volume by Country (2018-2023)
6.1.3 Europe Chagas Disease Treatment Sales in Value by Country (2018-2023)
6.2 Europe Chagas Disease Treatment Forecasted Market Size by Country
6.2.1 Europe Chagas Disease Treatment Sales in Volume by Country (2024-2029)
6.2.2 Europe Chagas Disease Treatment Sales in Value by Country (2024-2029)
7 Asia-Pacific Chagas Disease Treatment by Region
7.1 Asia-Pacific Chagas Disease Treatment Historic Market Size by Region
7.1.1 Asia-Pacific Chagas Disease Treatment Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Chagas Disease Treatment Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Chagas Disease Treatment Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Chagas Disease Treatment Forecasted Market Size by Region
7.2.1 Asia-Pacific Chagas Disease Treatment Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Chagas Disease Treatment Sales in Value by Region (2024-2029)
8 Latin America Chagas Disease Treatment by Country
8.1 Latin America Chagas Disease Treatment Historic Market Size by Country
8.1.1 Latin America Chagas Disease Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Chagas Disease Treatment Sales in Volume by Country (2018-2023)
8.1.3 Latin America Chagas Disease Treatment Sales in Value by Country (2018-2023)
8.2 Latin America Chagas Disease Treatment Forecasted Market Size by Country
8.2.1 Latin America Chagas Disease Treatment Sales in Volume by Country (2024-2029)
8.2.2 Latin America Chagas Disease Treatment Sales in Value by Country (2024-2029)
9 Middle East and Africa Chagas Disease Treatment by Country
9.1 Middle East and Africa Chagas Disease Treatment Historic Market Size by Country
9.1.1 Middle East and Africa Chagas Disease Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Chagas Disease Treatment Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Chagas Disease Treatment Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Chagas Disease Treatment Forecasted Market Size by Country
9.2.1 Middle East and Africa Chagas Disease Treatment Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Chagas Disease Treatment Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Nortec Quimica SA
10.1.1 Nortec Quimica SA Company Information
10.1.2 Nortec Quimica SA Introduction and Business Overview
10.1.3 Nortec Quimica SA Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Nortec Quimica SA Chagas Disease Treatment Products Offered
10.1.5 Nortec Quimica SA Recent Development
10.2 Bayer AG
10.2.1 Bayer AG Company Information
10.2.2 Bayer AG Introduction and Business Overview
10.2.3 Bayer AG Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer AG Chagas Disease Treatment Products Offered
10.2.5 Bayer AG Recent Development
10.3 Laboratorio Elea Phoenix SA
10.3.1 Laboratorio Elea Phoenix SA Company Information
10.3.2 Laboratorio Elea Phoenix SA Introduction and Business Overview
10.3.3 Laboratorio Elea Phoenix SA Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Laboratorio Elea Phoenix SA Chagas Disease Treatment Products Offered
10.3.5 Laboratorio Elea Phoenix SA Recent Development
10.4 Maprimed S.A
10.4.1 Maprimed S.A Company Information
10.4.2 Maprimed S.A Introduction and Business Overview
10.4.3 Maprimed S.A Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Maprimed S.A Chagas Disease Treatment Products Offered
10.4.5 Maprimed S.A Recent Development
10.5 Laboratorio Farmaceutico De Pernambuco
10.5.1 Laboratorio Farmaceutico De Pernambuco Company Information
10.5.2 Laboratorio Farmaceutico De Pernambuco Introduction and Business Overview
10.5.3 Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Products Offered
10.5.5 Laboratorio Farmaceutico De Pernambuco Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information
10.6.2 AstraZeneca Introduction and Business Overview
10.6.3 AstraZeneca Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.6.4 AstraZeneca Chagas Disease Treatment Products Offered
10.6.5 AstraZeneca Recent Development
10.7 Daiichi Sankyo Company Ltd
10.7.1 Daiichi Sankyo Company Ltd Company Information
10.7.2 Daiichi Sankyo Company Ltd Introduction and Business Overview
10.7.3 Daiichi Sankyo Company Ltd Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Daiichi Sankyo Company Ltd Chagas Disease Treatment Products Offered
10.7.5 Daiichi Sankyo Company Ltd Recent Development
10.8 Eisai Co Ltd
10.8.1 Eisai Co Ltd Company Information
10.8.2 Eisai Co Ltd Introduction and Business Overview
10.8.3 Eisai Co Ltd Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Eisai Co Ltd Chagas Disease Treatment Products Offered
10.8.5 Eisai Co Ltd Recent Development
10.9 GlaxoSmithKline Plc
10.9.1 GlaxoSmithKline Plc Company Information
10.9.2 GlaxoSmithKline Plc Introduction and Business Overview
10.9.3 GlaxoSmithKline Plc Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GlaxoSmithKline Plc Chagas Disease Treatment Products Offered
10.9.5 GlaxoSmithKline Plc Recent Development
10.10 KaloBios Pharmaceuticals, Inc
10.10.1 KaloBios Pharmaceuticals, Inc Company Information
10.10.2 KaloBios Pharmaceuticals, Inc Introduction and Business Overview
10.10.3 KaloBios Pharmaceuticals, Inc Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.10.4 KaloBios Pharmaceuticals, Inc Chagas Disease Treatment Products Offered
10.10.5 KaloBios Pharmaceuticals, Inc Recent Development
10.11 Kancera AB
10.11.1 Kancera AB Company Information
10.11.2 Kancera AB Introduction and Business Overview
10.11.3 Kancera AB Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Kancera AB Chagas Disease Treatment Products Offered
10.11.5 Kancera AB Recent Development
10.12 Novartis AG
10.12.1 Novartis AG Company Information
10.12.2 Novartis AG Introduction and Business Overview
10.12.3 Novartis AG Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Novartis AG Chagas Disease Treatment Products Offered
10.12.5 Novartis AG Recent Development
10.13 Oblita Therapeutics BVBA
10.13.1 Oblita Therapeutics BVBA Company Information
10.13.2 Oblita Therapeutics BVBA Introduction and Business Overview
10.13.3 Oblita Therapeutics BVBA Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Oblita Therapeutics BVBA Chagas Disease Treatment Products Offered
10.13.5 Oblita Therapeutics BVBA Recent Development
10.14 Sanofi Aventis
10.14.1 Sanofi Aventis Company Information
10.14.2 Sanofi Aventis Introduction and Business Overview
10.14.3 Sanofi Aventis Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Sanofi Aventis Chagas Disease Treatment Products Offered
10.14.5 Sanofi Aventis Recent Development
10.15 Grupo Praxis Pharmaceutical SA
10.15.1 Grupo Praxis Pharmaceutical SA Company Information
10.15.2 Grupo Praxis Pharmaceutical SA Introduction and Business Overview
10.15.3 Grupo Praxis Pharmaceutical SA Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Grupo Praxis Pharmaceutical SA Chagas Disease Treatment Products Offered
10.15.5 Grupo Praxis Pharmaceutical SA Recent Development
10.16 Johnson & Johnson
10.16.1 Johnson & Johnson Company Information
10.16.2 Johnson & Johnson Introduction and Business Overview
10.16.3 Johnson & Johnson Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Johnson & Johnson Chagas Disease Treatment Products Offered
10.16.5 Johnson & Johnson Recent Development
10.17 ELEA SACIF Laboratory
10.17.1 ELEA SACIF Laboratory Company Information
10.17.2 ELEA SACIF Laboratory Introduction and Business Overview
10.17.3 ELEA SACIF Laboratory Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.17.4 ELEA SACIF Laboratory Chagas Disease Treatment Products Offered
10.17.5 ELEA SACIF Laboratory Recent Development
10.18 F. Hoffmann-La Roche Ltd.
10.18.1 F. Hoffmann-La Roche Ltd. Company Information
10.18.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.18.3 F. Hoffmann-La Roche Ltd. Chagas Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.18.4 F. Hoffmann-La Roche Ltd. Chagas Disease Treatment Products Offered
10.18.5 F. Hoffmann-La Roche Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Chagas Disease Treatment Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Chagas Disease Treatment Industrial Chain Analysis
11.4 Chagas Disease Treatment Market Dynamics
11.4.1 Chagas Disease Treatment Industry Trends
11.4.2 Chagas Disease Treatment Market Drivers
11.4.3 Chagas Disease Treatment Market Challenges
11.4.4 Chagas Disease Treatment Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Chagas Disease Treatment Distributors
12.3 Chagas Disease Treatment Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
